Akava Therapeutics

Akava Therapeutics is a leading biopharmaceutical company focused on developing first-in-class small molecule therapies that treat various neurodegenerative diseases and cancers by inhibiting key pathways of neural crest targets. AKAVA's mission is to discover and develop first-in-class inhibitory therapies to address unmet medical needs in the fields of neurodegenerative diseases and oncology, enabling patients to extend their lifespan and improve their quality of life.